JCEM:骨质疏松症与帕金森氏病风险的关系

2020-11-25 MedSci原创 MedSci原创

骨质疏松症与PD风险增加有关,尤其是女性。

骨质疏松症和帕金森氏症(PD)经常并发,即使是早期PD患者,其骨密度水平也可能降低。这可能意味着骨质疏松症与较高的PD风险有关。近日,内分泌和代谢性疾病领域权威杂志Journal of Clinical Endocrinology & Metabolism上发表了一篇研究文章,该研究旨在明确骨质疏松症患者随后患PD的风险是否升高。

研究人员使用台湾国家健康保险研究数据库进行了回顾性队列研究。骨质疏松症组共纳入了23495名年龄在50至80岁之间且在2002年至2006年之间患有骨质疏松症的受试者。对照组纳入了23495名没有骨质疏松症的倾向评分匹配患者。他们的倾向得分是使用Logistic回归模型计算的,该模型包括年龄、性别、合并症和社会经济状况。

骨质疏松症组发生PD的风险比(HR)是对照组的1.31倍(95%CI:1.13-1.50,p=0.0002)。骨质疏松症组的无PD生存率也明显低于对照组(p=0.0004)。按性别分层的分析表明,骨质疏松症妇女患PD的HR(HR为1.50,95%CI:1.27-1.77,p<0.0001)似乎比男性(HR为1.23,95%CI:0.93-1.64),p=0.15)高。

本研究结果表明,骨质疏松症与PD风险增加有关,尤其是女性。

原始出处:

Shih-Hao Feng.et al.Osteoporosis and the risk of Parkinson’s disease: A nationwide propensity score-matched longitudinal follow-up study.JCEM.2020.https://doi.org/10.1210/clinem/dgaa864

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (19)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-10-13 smallant2015
  2. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-09-14 xieqian_78

    !!!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-12-02 lifefamily@163

    #骨质疏松症##帕金森氏病#风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,#雌激素#水平下降,机体呈现#退行性病变#。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-06-03 CWRCWR

    #骨质疏松#如何预防

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-03-02 achengzhao
  7. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-01-27 ms9000000710729683

    #学习#学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-01-14 ms9000000710729683

    学习了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1777999, encodeId=7cde1e7799916, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Oct 13 00:22:36 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820425, encodeId=b75518204258b, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Thu Apr 08 04:22:36 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051211, encodeId=0eb9105121127, content=!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f59a1355471, createdName=xieqian_78, createdTime=Tue Sep 14 17:20:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904248, encodeId=6bec90424868, content=<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>与<a href='/topic/show?id=4e334851457' target=_blank style='color:#2F92EE;'>#帕金森氏病#</a>风险增加有关,尤其是女性,我个人认为这个结论不可靠。尤其是女性,这两种疾病背后是同一个原因,<a href='/topic/show?id=c55098e5612' target=_blank style='color:#2F92EE;'>#雌激素#</a>水平下降,机体呈现<a href='/topic/show?id=45719468e93' target=_blank style='color:#2F92EE;'>#退行性病变#</a>。它们可能是并行的关系,而不是因果关系,只是骨质疏松严重的人,帕金森氏病可能概率也会高一些而已。, beContent=null, objectType=article, channel=null, level=null, likeNumber=238, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101869, encryptionId=e59810186916, topicName=骨质疏松症), TopicDto(id=48514, encryptionId=4e334851457, topicName=帕金森氏病), TopicDto(id=98756, encryptionId=c55098e5612, topicName=雌激素), TopicDto(id=94687, encryptionId=45719468e93, topicName=退行性病变)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Wed Dec 02 11:44:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970558, encodeId=95d99e0558f5, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a>如何预防, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=101862, encryptionId=fd3a1018623d, topicName=骨质疏松)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/0cb00ff0681a43df850f2c8f4f7814f0/d121f9de22ad4c53966f48be080e68ca.jpg, createdBy=7f085475251, createdName=CWRCWR, createdTime=Thu Jun 03 12:15:03 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063381, encodeId=de09206338111, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Mar 02 11:22:36 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920270, encodeId=78f59202e0f2, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:20:05 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920269, encodeId=490f92026918, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Wed Jan 27 12:19:29 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916416, encodeId=be7f916416e2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a85438556, createdName=ms9000000710729683, createdTime=Thu Jan 14 00:56:41 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908929, encodeId=f0179089299e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42435426428, createdName=ms8000001080131379, createdTime=Thu Dec 17 20:10:07 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-12-17 ms8000001080131379

    学习了

    0

相关资讯

Stroke:饮酒方式和缺血性卒中风险

在特定饮酒方式的中年参与者中,缺血性卒中的风险降低,但仅限于早期。考虑到饮酒方式与缺血性卒中之间的长期联系,医师在对患者饮酒的教育方面应保持谨慎。

Neurology:血管紧张素II刺激性降压药与痴呆症风险

血管紧张素II刺激性降压药服用者比血管紧张素II抑制性降压药服用者痴呆症发生率更低。尽管亚组分析表明这并不会影响结局,但必须进一步检查适应症。

Metabolism:MAFLD与CKD风险

MAFLD识别CKD患者的能力优于NAFLD。MAFLD和肝纤维化评分增加的MAFLD与CKD和蛋白尿密切相关。

Thorax:夜间轮班工作与哮喘风险增加相关

哮喘和轮班工作具有较高患病率和同时发生,这些结果对公共卫生的影响是深远的。需要进行纵向随访研究,以明确是否修改轮班工作时间表,以减少发生诸如哮喘等炎症性疾病的风险。

Br J Nutr :过犹不及!学者多年研究表明,每天1个鸡蛋,糖尿病风险大增60%

鸡蛋含有丰富的蛋白质、必需脂肪酸、维生素、矿物质、卵磷脂,鸡蛋是最有营养的食品。但是,胆固醇含量也很高,鸡蛋吃多了会堵塞血管,增加心脏病、脑中风和糖尿病的风险。然而,吃鸡蛋和糖尿病之间的联系尚不清楚。

JASN:儿童期癌症与ESKD风险

儿童期癌症与ESKD风险增加有关,提示需要进行更严格和更长的肾脏病随访。